- Home
- VCIG vs SILO Comparison
VCIG vs SILO Comparison
Compare VCIG & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCIG | SILO |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Apparel |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 8.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCIG | SILO |
|---|---|---|
| Price | $0.85 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 131.3K |
| Earning Date | 01-21-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | ★ $32,903,041.00 | $72,102.00 |
| Revenue This Year | N/A | $1.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.87 | ★ N/A |
| Revenue Growth | ★ 24.77 | N/A |
| 52 Week Low | $0.80 | $0.36 |
| 52 Week High | $1,344.00 | $3.37 |
Technical Indicators
Market Signals| Indicator | VCIG | SILO |
|---|---|---|
| Relative Strength Index (RSI) | 34.62 | 42.14 |
| Support Level | $0.89 | $0.42 |
| Resistance Level | $1.28 | $0.46 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 13.02 | 50.52 |
Price Performance
Historical ComparisonAbout VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.